170 related articles for article (PubMed ID: 34080560)
1. Racial differences in overdose training, naloxone possession, and naloxone administration among clients and nonclients of a syringe services program.
Jones AA; Park JN; Allen ST; Schneider KE; Weir BW; Hunt D; Sherman SG
J Subst Abuse Treat; 2021 Oct; 129():108412. PubMed ID: 34080560
[TBL] [Abstract][Full Text] [Related]
2. Take-home naloxone possession among people who inject drugs in rural West Virginia.
Allen ST; White RH; O'Rourke A; Grieb SM; Kilkenny ME; Sherman SG
Drug Alcohol Depend; 2019 Nov; 204():107581. PubMed ID: 31574407
[TBL] [Abstract][Full Text] [Related]
3. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
[TBL] [Abstract][Full Text] [Related]
4. Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015.
Nolan S; Buxton J; Dobrer S; Dong H; Hayashi K; Milloy MJ; Kerr T; Montaner J; Wood E
Public Health Rep; 2017; 132(5):563-569. PubMed ID: 28750193
[TBL] [Abstract][Full Text] [Related]
5. Knowledge of naloxone and take-home naloxone programs among a sample of people who inject drugs in Australia: Variations across capital cities.
Dietze PM; Stare M; Cogger S; Nambiar D; Olsen A; Burns L; Lenton S
Drug Alcohol Rev; 2018 May; 37(4):457-463. PubMed ID: 29744979
[TBL] [Abstract][Full Text] [Related]
6. Polysubstance use in rural West Virginia: Associations between latent classes of drug use, overdose, and take-home naloxone.
Schneider KE; O'Rourke A; White RH; Park JN; Musci RJ; Kilkenny ME; Sherman SG; Allen ST
Int J Drug Policy; 2020 Feb; 76():102642. PubMed ID: 31918401
[TBL] [Abstract][Full Text] [Related]
7. Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives.
Lintzeris N; Monds LA; Bravo M; Read P; Harrod ME; Gilliver R; Wood W; Nielsen S; Dietze PM; Lenton S; Shanahan M; Jauncey M; Jefferies M; Hazelwood S; Dunlop AJ; Greenaway M; Haber P; Ezard N; Malcom A
Drug Alcohol Rev; 2020 Jan; 39(1):55-65. PubMed ID: 31774221
[TBL] [Abstract][Full Text] [Related]
8. Fatal overdose prevention and experience with naloxone: A cross-sectional study from a community-based cohort of people who inject drugs in Baltimore, Maryland.
Buresh M; Gicquelais RE; Astemborski J; Kirk GD; Mehta SH; Genberg BL
PLoS One; 2020; 15(3):e0230127. PubMed ID: 32160244
[TBL] [Abstract][Full Text] [Related]
9. Take-Home Naloxone and risk management from the perspective of people who survived an opioid overdose in Stockholm - An analysis informed by drug, set and setting.
Holmén E; Hammarberg A; Kåberg M; Storbjörk J
Int J Drug Policy; 2023 May; 115():104021. PubMed ID: 37011507
[TBL] [Abstract][Full Text] [Related]
10. Racial disparities in use of syringe service programs in King County, WA: a comparison of two cross-sectional surveys.
Salow K; Jack HE; Tinsley J; Banta-Green CJ; Kingston S; Iles-Shih M; Tsui JI; Glick S
Harm Reduct J; 2023 Sep; 20(1):133. PubMed ID: 37704989
[TBL] [Abstract][Full Text] [Related]
11. "Once I'd done it once it was like writing your name": Lived experience of take-home naloxone administration by people who inject drugs.
McAuley A; Munro A; Taylor A
Int J Drug Policy; 2018 Aug; 58():46-54. PubMed ID: 29803097
[TBL] [Abstract][Full Text] [Related]
12. Patterns of polysubstance use and overdose among people who inject drugs in Baltimore, Maryland: A latent class analysis.
Schneider KE; Park JN; Allen ST; Weir BW; Sherman SG
Drug Alcohol Depend; 2019 Aug; 201():71-77. PubMed ID: 31195347
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and correlates of carrying naloxone among a community-based sample of opioid-using people who inject drugs.
Reed M; Wagner KD; Tran NK; Brady KA; Shinefeld J; Roth A
Int J Drug Policy; 2019 Nov; 73():32-35. PubMed ID: 31336291
[TBL] [Abstract][Full Text] [Related]
14. Injection Drug Use Frequency Before and After Take-Home Naloxone Training.
Colledge-Frisby S; Rathnayake K; Nielsen S; Stoove M; Maher L; Agius PA; Higgs P; Dietze P
JAMA Netw Open; 2023 Aug; 6(8):e2327319. PubMed ID: 37540514
[TBL] [Abstract][Full Text] [Related]
15. Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use.
Curtis M; Dietze P; Aitken C; Kirwan A; Kinner SA; Butler T; Stoové M
Harm Reduct J; 2018 Sep; 15(1):48. PubMed ID: 30241532
[TBL] [Abstract][Full Text] [Related]
16. Naloxone and the Inner City Youth Experience (NICYE): a community-based participatory research study examining young people's perceptions of the BC take home naloxone program.
Mitchell K; Durante SE; Pellatt K; Richardson CG; Mathias S; Buxton JA
Harm Reduct J; 2017 Jun; 14(1):34. PubMed ID: 28592287
[TBL] [Abstract][Full Text] [Related]
17. High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants.
Barocas JA; Baker L; Hull SJ; Stokes S; Westergaard RP
Drug Alcohol Depend; 2015 Sep; 154():283-6. PubMed ID: 26143300
[TBL] [Abstract][Full Text] [Related]
18. Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.
O'Brien DC; Dabbs D; Dong K; Veugelers PJ; Hyshka E
BMC Health Serv Res; 2019 Sep; 19(1):632. PubMed ID: 31488142
[TBL] [Abstract][Full Text] [Related]
19. Naloxone distribution and possession following a large-scale naloxone programme.
Madah-Amiri D; Gjersing L; Clausen T
Addiction; 2019 Jan; 114(1):92-100. PubMed ID: 30129078
[TBL] [Abstract][Full Text] [Related]
20. Knowledge of the Good Samaritan Drug Overdose Act and possession of a naloxone kit among people recently released from prison.
McLeod KE; Xavier J; Okhowat A; Williams S; Korchinski M; Young P; Papamihali K; Martin RE; Monaghan A; Sharifi N; Buxton JA
Int J Prison Health; 2021 Aug; ():. PubMed ID: 34633774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
